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has been considered a fatal disease with a relatively short duration of life after onset, although an unusually long duration has been observed in some cases~ Lee states, VlThe prognosis is inevitably fatal s but it must be remembered that this is a chronic diseasel> the duration of "Which varies from several months to many years o "
In the true form of polycythemia s the usual duration even alter diagnosis, which is usually not established for over a year D is a number of years (3)0 Symptomatic relief and control of the hematologic picture have been possible in many patients by means of venesections" phenylhydrazine given orall;y or roentgen irradiation, but there has been reported no large series of patients treated and observed for a long period in which evidence has been presented that there has been satisfactory control of the disease and marked lengthening of life o, Richardson and Robbins (4) treated 9 since 1932~ 28 patients with total body roentgen irradiation, and they concluded that theirresul ts sho1'; that their method of therapy is superior to venesection or phenylhydrazine therapyo In the 12 patients viho died$ the caUses of death were: pulmonary disease not related to ,the poly-,cythGIDia (2), carcinoma of the breast (1\) uremia due to prostatic obstruction (1), arterial thromboses (6; 3 coronary, 2 cerebral and 1 cerebral, aortic and subclavicular), the primary disease (1) and pulmonary embolism (1)0 In a series *Based on a presentation before the annual meeting of the American College of PhysiciansI ' San Francisco, Apri123" 1948 0 This work has been supported in part by the Henry stevens Kiersted Memorial Fund for Medical R~search and by the Thiarkle FoundationG During the past three year~ the p32 used in these studies has been provided by the Atomic Energy Comrnission o reported by Tinney and his co-workers (5) there was definite evidence that 36 out of 163 patients survived more than f'ive years a.f'l:;er onset o Common-causes of death have been:,~hromboses (6) in various arteries or veins D hemorrhage~the development of leukemia or anemia and infectious D neop~astic or other intercurtent'disease.
In the absence of methods for preventing the diseaseD one is ,forced to look for methods of keeping the number of red blood cells normal or near normal., If this can be done,. these patients are usually sympton free» and they may be less8usceptible to thrombotic complications.. In 1938, after extensive animal and cHIrl.cal studies with radioactive phosphorus , it was found possible to give nonlethal doses, of sodium radiophospha.te to animals an.d cause inhibition of cell production in thernarrow (7)0 The phosphate containing p32 (half-life approximately 2 weeks) localized 'to a marked degree in bone v bone marrow and rapi dly grom ng ti s sue such as I eukemi c ti s sue (8) I
and it the'refore seemed possible that one might have here a simple, method for the inhibition of red cell production inpolycythemia,verao Consequen~~y we administered the material to 2 pati ents with polycythemia vera~ their hemato1ogic~'ourse since that time .ls shown in Figure 1 and 2.. These patients were reported~inthe original article (9) 0 The doses given were calculated ~d extrapolated after: extensive experiencewith the effect ofp32 on the hematopoietic tissues of anima.ls and human beings (ibl& It is seen that in both of these patients the nUmber:of-red blood cells has been kept at normal or near normal levels with the infrequent use of p32 and the s~ptoms and signs of the disease have likewise been controlled during this period.
Since:the treatment of these f'i rst 2 pati ents we have treated:i..n' similar fashion 119 more patients suffering from polycythemia vera and have complete followup records on ll6 of these patients" Figures 3»,,4 showed myelocytes in theperiphe,ral blood after p32 therapy but not beforeo In no patient with a nomal tota~ white cell count when seen here initially were there I myelocytes in the peripheralbloo,i afterp32 therapy but not before~ Thirty-three percent had an elevated blood pressureD and 35 percent of these had a fall of their elevated blood pressure after p32 therapy.. This is interesting inV!ew of the possible relationship of the probably slowed renal blood flow and consequent renal hypoxia (12)0 There was a peptic ulcer or a history of it in 11.,5 percent; 14 0 8 percent had a thrombotic historyo
The. diagnosis of polycythemia vera was made from thehistorYephysical examination and the laboratory findings j) inclu~ing sternal marrow examInation (table) before and after therapy (13) When necessarYI> arterial blood oxygen saturation 1Ivas done to rule out secondary polycythemia (14) I> as were special pulmonary and cardiac studi~s if indicatedo The degree of unexplained polycythemia had to be 7,000,9000 or above before the diagnosis was made 9 unlessthere were cleancut evidence of the di~gnosis in the past or an enlarged spleen with a definitely elevated red blood cell countc In borderline cases, the red cell mass as determined by 1'32 labelled cells and the measurement of red cell production with,'Fe 59 were often helpful in diagnosiso (1) and cerebral thrombosis (I).. Exclud.ing the patient with porta.ithrambosis which had developed prior to our seeing or treating the patients the average age of death in this series was 67,,* It is to be noted that there were 5 deaths associ ated with leukemia" or about 4 percent of the treated group" The high incidence of leukemia as .a complication of polycythemia vera is well known (15)" As pointed out by Moschowitz (15)1) Since the writing 'of this paper.\> there have been 3 more deathsg 1 from circulatory fe.ilurefollowing wides1?read thromboses which had developed prior to p32, and 2 from causes urikQwns·but none from leukemia or the disease-itself" **Sinceihls article was written, Dro No Rosenthal (personal communication to the author) has obser'lTed 8 more pati ents suffering from _ polycythemia vera» untreated by any fonn.of radiations who developed a marked leul<:emoid reaction or a leukemia as a, complication ... Two of these patients had a blood picture indistinguishable from chronicTIlyelogenous leukemia.. The following are the white cell coUnts and abnormal white cells in these patients: . In our own series of 172 patients g we also have three living patientswith polycythemia complicated by a blood and marrow picture indistinguishable from chronic myelogenous Jeukemia (2 cases) and erythro~leukemia (lozcase)" Two of these patients had received no previous x-ray and none had received pv2" " ..
'.
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Klumpp and Hertig (15) report 5 cases in which myelogenous leukeraia occurred as a complication of polycythemia vera. In 3 of these there had been no previous therapy with x-ray or any other form of radiation. Hansen-Pruss and Goodman (15) report 2 cases of polycythenlia vera under treatment with x-ray who died with the picture of acute leukemia. Kraus and Schiller (15) report a complicating leukemia in a patient polycythemia vera. The patient had never received any form of radiation., Schoen (15) reports leukernia developing in polycythemia vera apparently before any radiation therapy was given. nnney et a1~ (15) x-ray, and phenylhydrazine. 'Vi'hen we first saw her, the red blood cells numbered over 10 9 000,000 9 but after a course of p32 therapy, these were reduced to normal levels, and the patient remained in remission 1.intil 2 years later when she again developed an elevated red cell count (8,000,000) with approximately 20s000·white cells. No immature white cells were noted in the blood smear.. Three doses of radioactive phosphorus totaling 9.98 me. were adrninistered ll but the red cell count remained around 8,000 3 000 and the 'white count around 20,000.. One year later the red cell count was over 8,000 3 000 and the white cell count had risen to 44J)000. The Thus it seems thEj.t there is no Significant iD:crease in the incidence of leukemia 32 after P therapyo Also" the connnon leukemoid reaction seen a.t the outset of therapy di sappeared in over 70 percent of the ca.ses· after therapy with p32" There is no evidence of the consistent occurrence of other complications which might be related to the treatment o For example» there is no evidence that neoplasms are being induced by this therapy, the three we observed occurring soon after the beginning of therapy and probably related to the normal probability of the development of neoplastic disease (carcinoma of head of pancreas, carcinoma of prostate and carcinoma of kidney) in patients in this age groupo Also of interest are the few thromboses observed so fa.r in this series (402 percent)o Hall (11) found in a series of 124 patient" "vith polycythemia that
there was a history of thrombosis in 27perc'ent of them, whereas after P the incidence of tlirombosis was only 204. percent. This is probably related to the fact that the red cell mass», plateletsJ and blood viscosity have been kept normal.
With the present methods for the control of polycythemia. and high incidence of serious thromboses in the past (16)s it can not be emphasized too strongly that the numbers of the red cells and platelets of these patients should, always be kept wi thin normal Hmi ts in order to avoid damage to the vascular 'systemo Such control of the red cell mass (as measure'd by accurate blood -volume determinations) can be , .. achieved only by adequate follow.:.up and frequent observation of all patients after they are treated o This applies particularly to patients in the older age group with high thrombocyte counts. Radiation is especially effective in controlling both of these formed e1 ements of the blood. In this connection» it is of interest
to observe that many of the patients treated with P were previously uncontrolled FinallyI' since patients with polycythemia vera are usually not in the child-bearing age group' and since the doses of radiation. are extremely small (17) s the possible
genetic effects of irradiation on subsequent generations need not be considered ..
Although this series must be extended in number and then followed for many more years, certain comments seem in order e First» the average age of onset of ... . . o Z 557
